Keywords: Almirall, Forest Labs, Linaclotide, Commercialization rights, MExico, IBS-C

Almirall gains rights for IBS drug linaclotide in Mexico

Article | 10 September 2012

Print This

Spain’s largest drugmaker Almirall (ALM. MC) says it has reached an agreement with USA-based Forest Laboratories (NYSE: FRX) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in